On Monday US equities gained on positive news around coronavirus treatments and relaxing US-China relations.
Business Insider reports that Food and Drug Administration issued emergency authorization for using plasma to treat COVID-19.
The White House is looking to fast-track AstraZeneca's experimental coronavirus vaccine, according to the Financial Times.